Advertisements


ARCA Biopharma jumps after announcing data from Genetic-AF trial presentation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 11th, 2019

ARCA Biopharma announces GENETIC-AF trial data published

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 1st, 2019

ARCA Biopharma announces data from AFB substudy of GENETIC-AF trial at AHA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2018

ARCA Biopharma presents GENETIC-AF Phase 2B clinical trial results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 29th, 2018

Adverum Shares Sink After Phase 1 Readout From Wet AMD Gene Therapy Trial

Adverum Biotechnologies Inc (NASDAQ: ADVM) shares were plunging Thursday following the presentation of data from its gene therapy trial at a conference. read more.....»»

Category: blogSource: benzingaSep 12th, 2019

Microbot Medical jumps over 5% after announcing presentation plans for SCS

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 5th, 2019

Novavax announces presentation of data from Phase 3 Prepare trial of ResVax

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 12th, 2019

Boston biotech Rhythm"s stock jumps on success of drug for rare form of obesity

Shares of Boston startup Rhythm Pharmaceuticals jumped 20 percent Wednesday after the company announced its drug for two genetic forms of obesity succeeded in a late-stage trial. In a phase 3 trial, Rhythm’s (Nasdaq: RYTM) drug setmelanotide was .....»»

Category: topSource: bizjournalsAug 7th, 2019

Principia Biopharma expects to announce data from Phase 2 trial in Q4

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 30th, 2019

Array BioPharma to present data from Phase 3 COLUMBUS trial at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 29th, 2019

Payment Data Systems jumps over 7% after announcing pact with Pineapple Payments

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 21st, 2019

ARCA Biopharma files provisional patent application after GENETIC-AF findings

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 13th, 2019

RA Pharmaceuticals says Phase 2 zilucoplan trial data selected for presentation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2019

ARCA Biopharma announces publication of PDE3A gene data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 18th, 2019

Here"s Why Blueprint Medicines Fell as Much as 15.1% Today

The biopharma reported encouraging data from a phase 1 trial. Er, wait, what?.....»»

Category: topSource: foxnewsApr 16th, 2018

Array BioPharma to present Phase 3 COLUMBUS trial data at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

Morning Movers: Pepsi Jumps, Celgene Climbs, Chipotle Slides

The Dow Jones industrial Average looks set to gain for a fourth consecutive day. Plus, Pepsi's earnings, Celgene's trial data, and Chipotle's downgrade......»»

Category: blogSource: barronsJul 10th, 2018

Theravance Biopharma reports "positive" data from Phase 2 trial of TD-9855

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

Applied Genetic reports interim data from rAAV2tYF-CB-hRS1 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 12th, 2018

Array BioPharma announces updated safety, efficacy data from BEACON CRC trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 14th, 2019

ARCA Biopharma announces FDA agreement for Phase 3 PRECISION-AF trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 20th, 2019